Latest News in the pharma Industry

Top Stories

BioInvent & Servier Form Antibody Collaboration

BioInvent & Servier Form Antibody Collaboration

5 Jan 2012

Servier will have access to BioInvent's in-house pre-clinical capacities in selecting an antibody candidate for development.

Read more 
Isotechnika Signs License Agreement with Vifor

Isotechnika Signs License Agreement with Vifor

4 Jan 2012

Isotechnika has inked a deal with Swiss-based drug maker Vifor to commercialize the company’s lead drug candidate voclosporin for treatment of lupus.

Read more 
Teva Announces New CEO

Teva Announces New CEO

4 Jan 2012

Teva has named Dr. Jeremy Levin, a former senior executive at Bristol-Myers Squibb, to succeed Shlomo Yanai as new CEO in May.

Read more 
Regeneron Ends Patent Litigation with Genentech

Regeneron Ends Patent Litigation with Genentech

4 Jan 2012

Under the terms of the Agreement, Regeneron will make payments to Genentech based on U.S. sales of EYLEA through May 7, 2016.

Read more 
Alexion Pharmaceuticals to Acquire Enobia Pharma

Alexion Pharmaceuticals to Acquire Enobia Pharma

30 Dec 2011

Alexion Pharmaceuticals plans to buy drug developer Enobia Pharma in a deal that could be worth $1.08 billion.

Read more 
OPKO Completes Acquisition of FineTech Pharmaceutical

OPKO Completes Acquisition of FineTech Pharmaceutical

30 Dec 2011

OPKO Health has completed the acquisition of Israel-based FineTech which produces high potency active pharmaceutical ingredients.

Read more 
Immunomedics & UCB Amend Epratuzumab Deal

Immunomedics & UCB Amend Epratuzumab Deal

29 Dec 2011

The restructuring provides UCB with the flexibility to select a partner to sublicense its rights for certain territories.

Read more 
Pharmexcil Expects More International Exposure with New Council Name

Pharmexcil Expects More International Exposure with New Council Name

29 Dec 2011

The change in the council’s name is to have a better visibility and to give more exposure of the council’s activities in the national and international forums.

Read more 
BI to Expand Manufacturing Plant in China

BI to Expand Manufacturing Plant in China

28 Dec 2011

Boehringer Ingelheim is investing €70m in China to expand its Shanghai manufacturing facility.

Read more 
Eisai Resubmits Perampanel NDA to FDA

Eisai Resubmits Perampanel NDA to FDA

27 Dec 2011

Eisai has resubmitted the New Drug Application for the investigational AMPA-type glutamate receptor antagonist perampanel.

Read more 
Karo Bio Forms Research Collaboration with Pfizer

Karo Bio Forms Research Collaboration with Pfizer

27 Dec 2011

The collaboration aims to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.

Read more 
Marina Biotech & Mirna Therapeutics Ink Oncology Pact

Marina Biotech & Mirna Therapeutics Ink Oncology Pact

26 Dec 2011

Marina Biotech could receive up to $63 million in total up-front fees as well as clinical and commercialization milestone payments over and above royalties on sales.

Read more